医学
重症监护医学
疾病
肾脏疾病
梅德林
内科学
政治学
法学
出处
期刊:JAMA
[American Medical Association]
日期:2025-04-11
卷期号:333 (18): 1571-1571
被引量:1
标识
DOI:10.1001/jama.2025.4028
摘要
Updated guidelines for managing chronic kidney disease (CKD) now recommend that all patients with type 2 diabetes use sodium-glucose cotransporter-2 (SGLT2) inhibitors, according to a synopsis published in Annals of Internal Medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI